Danaher Corporation $DHR Shares Sold by Arax Advisory Partners

Arax Advisory Partners reduced its holdings in shares of Danaher Corporation (NYSE:DHR) by 74.1% in the 4th quarter, HoldingsChannel reports. The fund owned 9,930 shares of the conglomerate’s stock after selling 28,457 shares during the quarter. Arax Advisory Partners’ holdings in Danaher were worth $2,273,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. JPL Wealth Management LLC acquired a new position in shares of Danaher during the 3rd quarter worth about $25,000. Elevated Capital Advisors LLC acquired a new position in shares of Danaher during the 4th quarter worth about $26,000. WFA of San Diego LLC acquired a new position in shares of Danaher during the 2nd quarter worth about $26,000. ANTIPODES PARTNERS Ltd acquired a new position in shares of Danaher during the 3rd quarter worth about $27,000. Finally, Hilton Head Capital Partners LLC acquired a new position in shares of Danaher during the 4th quarter worth about $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DHR has been the subject of several analyst reports. HSBC lowered their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Argus reduced their target price on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. Rothschild & Co Redburn set a $205.00 target price on Danaher in a report on Friday, April 17th. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Finally, Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $233.61.

Key Stories Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher closed its $9.9 billion acquisition of Masimo, expanding its diagnostics and patient-monitoring portfolio with AI-enabled sensor technologies that could support longer-term growth. Danaher Boosts Product Portfolio With the Acquisition of Masimo
• Positive Sentiment: Cepheid, a Danaher company, donated Xpert Hemorrhagic Fever panel tests to support Ebola outbreak response in Africa, highlighting the company’s diagnostic relevance and public-health role. Cepheid Delivers Xpert Hemorrhagic Fever Panel Tests to Africa
• Positive Sentiment: Analysts noted strong performance in Danaher’s biotechnology unit, with bioprocessing demand and equipment orders rising, which supports the company’s 2026 growth outlook. Strong Performance Continues at DHR’s Biotechnology Unit: What’s Next?

Danaher Trading Down 0.1%

Shares of DHR stock opened at $179.95 on Monday. The business’s 50 day moving average is $180.93 and its two-hundred day moving average is $204.62. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a market capitalization of $127.37 billion, a P/E ratio of 34.81, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the business posted $1.88 EPS. The company’s revenue was up 3.7% on a year-over-year basis. Equities analysts forecast that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.